Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 30, 2025

Stock market today: Dow, S&P 500, Nasdaq waver as Fed minutes show division over December rate cut

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq waver as Fed minutes show division over December rate cut US stocks wavered after the opening bell on Tuesday, as Wall Street looked to regroup after a tech-led slide to begin the final stretch of 2025…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If federal budgetary actions push the market downward, Molina's shares could drop below $100, which he labeled a generational buy.

    80% confidence
  • Molina Healthcare has a clearer path to significant double-digit long-term growth than Apple.

    80% confidence
  • Globally, supply on metals from lithium to cobalt has been heavily constrained by a mixture of government policy and natural resource decline, and mining companies have faced a mix of pressures including ESG policies, long permitting timelines, and self-imposed capital efficiency requirements following the commodity price bust in the 2010s.

    80% confidence
  • Michael Burry stated he would acquire Molina Healthcare if he had the funds.

    80% confidence
  • Molina Healthcare has the best loss ratio, best expense ratio, best win rate, and most conservative accounting among insurers.

    80% confidence
  • Tesla estimated Q4 deliveries at a 15% drop compared to the same period last year.

    80% confidence
  • Metals and mining sector tailwinds should continue in early 2026, and the sector should outperform again as a result.

    80% confidence
  • We're in a metals war

    80% confidence
  • Most participants judged that further downward adjustments to the target range for the federal funds rate would likely be appropriate if inflation declined over time as expected.

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Stock market today: Dow, S&P 500, Nasdaq waver as Fed minutes show division over December rate cut — Source | Via News | Via News